Prevalence and diversity of Clostridium difficile strains in infants

Clotilde Rousseau1,2, Ludovic Lemée3,4, Alban Le Monnier5,2

  • 1Service de Microbiologie, Hôpital Jean Verdier, Assistance Publique - Hôpitaux de Paris, Bondy, France.

Insights

Infants frequently carry Clostridium difficile, with 33.7% colonized. Toxigenic strains, including adult infectious types, were found in 7.1% of infants, suggesting they may act as reservoirs for C. difficile transmission.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Asymptomatic intestinal colonization by Clostridium difficile is common in early infancy.
  • Understanding infant colonization prevalence and strain characteristics is crucial for public health.

Purpose of the Study:

  • To determine the prevalence of Clostridium difficile colonization in infants aged 0-2 years.
  • To characterize infant C. difficile strains by virulence factors and phylogenetic diversity.
  • To assess the potential role of infants as reservoirs for adult C. difficile strains.

Main Methods:

  • Prospective screening of C. difficile in infant stools using toxigenic culture.
  • Molecular characterization via PCR-ribotyping (PRs) and multilocus sequence typing (MLST).

Main Results:

  • Overall C. difficile colonization prevalence was 33.7%, with 7.1% carrying toxigenic strains.
  • Community-acquired C. difficile accounted for 66.7% of cases.
  • Seventeen PCR ribotypes and 15 sequence types were identified; PRJV11-ST38 (non-toxigenic) was predominant.
  • Toxigenic strains, including some resembling adult infectious strains, were identified in asymptomatic infants.

Conclusions:

  • Infants are widely colonized by C. difficile, predominantly non-toxigenic strains.
  • Toxigenic C. difficile strains, including those known to cause severe infections in adults, circulate in asymptomatic infants.
  • Infants may serve as a reservoir for the community spread of adult C. difficile infectious strains.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.